Estimates Revisions Atossa Therapeutics, Inc.
Stocks
ATOS
US04962H7044
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.875 USD | -6.72% |
|
-20.85% | -78.98% |
| 06-11 | Top Midday Decliners | MT |
| 06-11 | Atossa Therapeutics Launches $16.5 Million Registered Direct Offering | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ATOS Stock
- Consensus Atossa Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
